Description
PT-141 (Bremelanotide) — Melanocortin Receptor Agonist
A synthetic cyclic heptapeptide melanocortin receptor agonist. PT-141 is studied in laboratory research for its selective activation of melanocortin receptors MC3R and MC4R, which are involved in multiple physiological signaling pathways.
Research Applications
- Melanocortin receptor binding studies
- MC3R/MC4R signaling pathway research
- Cyclic peptide structure-activity analysis
Product Specifications
Purity: ≥99% (HPLC-MS verified)
Form: Lyophilized powder
Content: 10mg per vial
Storage: -20°C, protected from light
⚠ Research Use Only: For in-vitro laboratory research. Not for human or animal consumption.
